The Nigerian Sovereign Investment Authority (NSIA) has convened critical oncology stakeholders and strategic partners at the maiden edition of the NSIA Oncology Summit in Lagos.
The move, according to a statement from NSIA on Wednesday, was to drive collaborations amongst partners and improve overall patient outcomes in cancer-care.
Participants at the Summit included over 200 medical professionals in oncology, over 11 Nigerian tertiary hospitals as well as over 10 external collaborators from the University of Chicago; American Oncology Institute India; American Society of Clinical Oncology (ASCO); Bio Ventures for Global Health (BVGH); Memorial Sloan Kettering Cancer Centre; American Association of Physicists in Medicine (‘AAPM’) and the University of Pittsburgh Medical Centre (UPMC).
At the Summit, medical professionals split into focal groups across various specialty areas to discuss barriers to oncology care in Nigeria, possible solutions to address same and retention plans for homegrown talent.
Speaking at the Oncology Summit, the Managing Director, NSIA, Aminu Umar-Sadiq, noted that “this is an important first step in bringing together key oncology stakeholders to enhance the quality of cancer care in Nigeria.”
